Latest Selling Leads
.
| Date | Name/CAS No. | Suppliers/Manufactures | Check | ||
|---|---|---|---|---|---|
| 04-15 09:56 | Ranevetmab 1632282-27-9 |
||||
| 04-15 09:56 | Brazikumab 1610353-18-8 |
||||
| 04-15 09:56 | Emapalumab 1709815-23-5 |
||||
| 04-15 09:56 | Crizanlizumab 1690318-25-2 |
||||
| 04-15 09:56 | Ravulizumab 1803171-55-2 |
||||
| 04-15 09:56 | Tomaralimab 1449294-76-1 |
||||
| 04-15 09:56 | Lupartumab 1640971-88-5 |
||||
| 04-15 09:56 | Rozanolixizumab 1584645-37-3 |
||||
| 04-15 09:56 | Duvortuxizumab 1831098-91-9 |
||||
| 04-15 09:56 | Eptinezumab 1644539-04-7 |
||||
| 04-15 09:56 | Elezanumab 1791416-49-3 |
||||
| 04-15 09:56 | Lutikizumab 1791411-57-8 |
||||
| 04-15 09:56 | Dezamizumab 1662664-56-3 |
||||
| 04-15 09:56 | Telisotuzumab 1781223-80-0 |
||||
| 04-15 09:56 | Vadastuximab 1436390-63-4 |
||||
| 04-15 09:56 | Carotuximab 1268714-50-6 |
||||
| 04-15 09:56 | Timolumab 1073538-99-4 |
||||
| 04-15 09:56 | Lanadelumab 1426055-14-2 |
||||
| 04-15 09:56 | Galcanezumab 1578199-75-3 |
||||
| 04-15 09:56 | Domagrozumab 1629605-31-7 |
